Lijun International Pharmaceutical (Holding) Co., Ltd. ("The Group") is one of the leading pharmaceutical manufacturers in the PRC with 7 decades of operation history and a well-established brand name. The Group is principally engaged in the research, development, manufacture and sale of a wide range of pharmaceutical products, including antibiotics, intravenous infusion solution, non-antibiotics finished medicines, bulk pharmaceuticals and OTC and healthcare products.
The Group is renowned for the production of antibiotics. The Group's antibiotics brand - Lijunsha 
was awarded the "Well-known Trademark" in 2002 and 2003 respectively, and the "Ten Most Favoured Brands Elected by the Public". The Group was also among the Top 100 Pharmaceutical Manufacturers in 2004. After the acquisition of Shijiazhuang No.4 Pharmaceutical Co., Ltd. in June 2007, an industry leader in infusion pharmaceutical in the PRC, the Group commenced its intravenous infusion solution business. Currently, the Group has the highest sales revenue in intravenous infusion solution on single factory basis in the PRC.
The Group went public on the Hong Kong Stock Exchange in December 2005 with stock code 2005.
updated 10th October, 2008
| © Copyright 1996-2009 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |